TradingView
warrenhochfeld
Nov 20, 2017 7:43 PM
Second Axsome AXSM buy opportunity
Long
NASDAQ:AXSM
120
Axsome Therapeutics, Inc.
NASDAQ
Description
⋅
Nov 20, 2017 7:43 PM
Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.
Trend Analysis
Beyond Technical Analysis
More